MBCL-46. TREATMENT OF RECURRENT WINGLESS-ACTIVATED MEDULLOBLASTOMA (Wnt-MB) INCORPORATING MARROW-ABLATIVE THIOTEPA AND CARBOPLATIN CHEMOTHERAPY (HDCx) AND AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL RESCUE (AuHPCR): A DUAL REPORT

BACKGROUND: Wnt-MB infers an excellent prognosis, and metastatic disease is rare. However, specific treatment strategies and patterns of failure for patients with recurrent Wnt-MB are unknown. We report two cases of recurrent beta-catenin nucleopositive Wnt-MBs treated with an irradiation-sparing st...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Harris, Micah K, Funk, Zachary N, Boué, Daniel R, Pierson, Christopher R, Jones, Jeremy, Leonard, Jeffrey, Abu-Arja, Rolla, Auletta, Jeffrey, Osorio, Diana S, Shatara, Margaret, Paul, Stephan R, Finlay, Jonathan L, AbdelBaki, Mohamed S
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Medulloblastoma (Clinical)
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715265/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.517
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados